LY-404187

More efficient, faster and cheaper. Ace Therapeutics are trustworthy.

sale

LY-404187

Specification
Cat. No.
SMD1630
Related Diseases
Schizophrenia
Related Diseases
Depression
Product Name
LY-404187
Size
50.0mg; 100.0mg; 200.0mg; 500.0mg; 1.0g; 2.0g
Price
Inquiry
Availability
2 Weeks
Description
LY-404187 is an ampakine, AMPA receptor potentiator. LY-404187 has been demonstrated to enhance cognitive function in animal studies, and has also shown effects suggesting antidepressant action as well as having possible application in the treatment of schizophrenia, Parkinson's disease and ADHD. These effects appear to be mediated through multiple mechanisms of action secondary to AMPA receptor potentiation, with a prominent effect seen in research being increased levels of BDNF in the brain.
CAS Number
211311-95-4
Chemical Formula
C19H22N2O2S
Exact Mass
342.1402
Molecular Weight
342.457
Elemental Analysis
C, 66.64; H, 6.48; N, 8.18; O, 9.34; S, 9.36
Synonym
LY-404187; LY 404187; LY404187.
IUPAC/Chemical Name
2-Propanesulfonamide, N-(2-(4'-cyano(1,1'-biphenyl)-4-yl)propyl)-
InChi Key
HOQAVGZLYRYHSO-UHFFFAOYSA-N
InChi Code
InChI=1S/C19H22N2O2S/c1-14(2)24(22,23)21-13-15(3)17-8-10-19(11-9-17)18-6-4-16(12-20)5-7-18/h4-11,14-15,21H,13H2,1-3H3
SMILES Code
CC(S(=O)(NCC(C1=CC=C(C2=CC=C(C#N)C=C2)C=C1)C)=O)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code
2934.99.9001
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Enter Your Email to Subscribe

Enter your E-mail and receive the latest news from us

Copyright © Ace Therapeutics. All Rights Reserved.
Top